InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Keson-Brookes Maiken. Officer active across 2 companies, notably Rubius Therapeutics, Inc.. In total, 9 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €25k. History available since 14 December 2023. The latest transaction was disclosed on 22 July 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Keson-Brookes Maiken is a declarant. The record shows 7 filings in total, and across the sampled recent filings there were no buys and EUR 14755 of sells between 2022-02-01 and 2025-03-05, mainly կապված with Mural Oncology plc and Rubius Therapeutics, Inc.